Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114836) titled 'Adebrelimab combined with irinotecan liposomal (ll), oxaliplatin, and 5-FU/LV conversion therapy for locally advanced pancreatic cancer: a prospective, single-arm, exploratory clinical study' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Jiangsu Provincial Hospital
Condition:
Pancreatic cancer
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2025-04-02
Target Sample Size: Experimental group:47;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=275533
Published by HT Digital Content Servic...